Engineered autophagy receptors administered with extracellular vesicles eliminate pathological Tau and TDP-43
- 26 August 2026
- journal article
- research article
- Published by Springer Nature in Nature Biomedical Engineering
- p. 1-19
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Contaminating transfection complexes can masquerade as small extracellular vesicles and impair their delivery of RNAJournal of Extracellular Vesicles, 2022
- Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALSActa Neuropathologica, 2015
- Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43Acta Neuropathologica, 2015
- Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron diseaseActa Neuropathologica, 2015
- Anti‐tau antibody reduces insoluble tau and decreases brain atrophyAnnals of Clinical and Translational Neurology, 2015
- Biochemical Isolation of Insoluble Tau in Transgenic Mouse Models of Tauopathies2012
- SQSTM1 Mutations in Familial and Sporadic Amyotrophic Lateral SclerosisArchives of Neurology, 2011
- Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesisActa Neuropathologica, 2010
- Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseasesActa Neuropathologica, 2008
- Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutationsAnnals of Neurology, 2007